Cargando…

Exploring the Potential of Zirconium-89 in Diagnostic Radiopharmaceutical Applications: An Analytical Investigation

This study highlights the use of (89)Zr-oxalate in diagnostic applications with the help of WinAct and IDAC2.1 software. It presents the biodistribution of the drug in various organs and tissues, including bone, blood, muscle, liver, lung, spleen, kidneys, inflammations, and tumors, and analyzes the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mostafa, Ahmed M. A., Zakaly, Hesham M. H., Issa, Shams A. M., Uosif, Mohamed A. M., Alrowaili, Ziyad A., Zhukovsky, Michael V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135474/ https://www.ncbi.nlm.nih.gov/pubmed/37189792 http://dx.doi.org/10.3390/biomedicines11041173

Ejemplares similares

The Influence of CoO/P(2)O(5) Substitutions on the Structural, Mechanical, and Radiation Shielding of Boro-Phosphate Glasses
por: Mostafa, Ahmed M. A., et al.
Publicado: (2021)

Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development
por: Pandya, Darpan N., et al.
Publicado: (2017)

Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution
por: Larenkov, Anton, et al.
Publicado: (2019)

Lead-Free Ternary Glass for Radiation Protection: Composition and Performance Evaluation for Solar Cell Coverage
por: Uosif, Mohamed A. M., et al.
Publicado: (2023)

Structure, Mössbauer, electrical, and γ-ray attenuation-properties of magnesium zinc ferrite synthesized co-precipitation method
por: Zakaly, Hesham M. H., et al.
Publicado: (2022)

Author Correction: Structure, Mössbauer, electrical, and γ-ray attenuation-properties of magnesium zinc ferrite synthesized co-precipitation method
por: Zakaly, Hesham M. H., et al.
Publicado: (2022)

Distribution of Radionuclides and Radiological Health Assessment in Seih-Sidri Area, Southwestern Sinai
por: Alharshan, Gharam A., et al.
Publicado: (2022)

Recent Advances in Zirconium-89 Chelator Development
por: Bhatt, Nikunj B., et al.
Publicado: (2018)

The Race for Hydroxamate-Based Zirconium-89 Chelators
por: Feiner, Irene V. J., et al.
Publicado: (2021)

An In-Depth Examination of the Natural Radiation and Radioactive Dangers Associated with Regularly Used Medicinal Herbs
por: Saudi, Heba A., et al.
Publicado: (2022)

Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89
por: Bhatt, Nikunj B., et al.
Publicado: (2017)

In Vitro and In Vivo Characterization of (89)Zirconium-Labeled Lintuzumab Molecule
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Radiopharmaceuticals: global market trajectory & analytics
Publicado: (2020)

Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease
por: Laban, Kamil G., et al.
Publicado: (2019)

Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
por: de Keizer, Bart, et al.
Publicado: (2019)

A new technique for the radiolabelling of mixed leukocytes with zirconium‐89 for inflammation imaging with positron emission tomography
por: Fairclough, M., et al.
Publicado: (2016)

A closer look at the efficiency calibration of LaBr(3)(Ce) and NaI(Tl) scintillation detectors using MCNPX for various types of nuclear investigations
por: ALMisned, Ghada, et al.
Publicado: (2022)

Trivalent Ions and Their Impacts on Effective Conductivity at 300 K and Radio-Protective Behaviors of Bismo-Borate Glasses: A Comparative Investigation for Al, Y, Nd, Sm, Eu
por: ALMisned, Ghada, et al.
Publicado: (2021)

Alternative Chelator for (89)Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)
por: Deri, Melissa A., et al.
Publicado: (2014)

Exploring the FTIR, Optical and Nuclear Radiation Shielding Properties of Samarium-Borate Glass: A Characterization through Experimental and Simulation Methods
por: Issa, Shams A. M., et al.
Publicado: (2021)

Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator
por: Alnahwi, Aiman H., et al.
Publicado: (2020)

Impact of Eye and Breast Shielding on Organ Doses During Cervical Spine Radiography: Design and Validation of MIRD Computational Phantom
por: Elshami, Wiam, et al.
Publicado: (2021)

Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals
por: de Blois, Erik, et al.
Publicado: (2019)

EANM guideline on the validation of analytical methods for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2020)

A Closer Look on Nuclear Radiation Shielding Properties of Eu(3+) Doped Heavy Metal Oxide Glasses: Impact of Al(2)O(3)/PbO Substitution
por: ALMisned, Ghada, et al.
Publicado: (2021)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Airaksinen, A, et al.
Publicado: (2016)

Tungsten (VI) oxide reinforced antimony glasses for radiation safety applications: A throughout investigation for determination of radiation shielding properties and transmission factors
por: AlMisned, Ghada, et al.
Publicado: (2023)

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images
por: Jauw, Yvonne W. S., et al.
Publicado: (2018)

Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Gamma-Ray Protection Properties of Bismuth-Silicate Glasses against Some Diagnostic Nuclear Medicine Radioisotopes: A Comprehensive Study
por: ALMisned, Ghada, et al.
Publicado: (2021)

Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe
por: Ahmed, Mona, et al.
Publicado: (2020)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Dorrer, H, et al.
Publicado: (2011)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
por: Perk, Lars R., et al.
Publicado: (2009)

In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles
por: Chen, Feng, et al.
Publicado: (2015)

Investigation of Er(3+) Ions Reinforced Zinc-Phosphate Glasses for Ionizing Radiation Shielding Applications
por: Zakaly, Hesham M. H., et al.
Publicado: (2021)

Utilization of artificial intelligence approach for prediction of DLP values for abdominal CT scans: A high accuracy estimation for risk assessment
por: Tekin, H. O., et al.
Publicado: (2022)

In-Silico Monte Carlo Simulation Trials for Investigation of V(2)O(5) Reinforcement Effect on Ternary Zinc Borate Glasses: Nuclear Radiation Shielding Dynamics
por: Tekin, Huseyin O., et al.
Publicado: (2021)

Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89
por: Zhai, Chuangyan, et al.
Publicado: (2019)

On the Versatility of Nanozeolite Linde Type L for Biomedical Applications: Zirconium-89 Radiolabeling and In Vivo Positron Emission Tomography Study
por: Lacerda, Sara, et al.
Publicado: (2022)

Engineering Intrinsically Zirconium‐89 Radiolabeled Self‐Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies
por: Goel, Shreya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p6c6v1dmo9kgkvlq3b8fijhoc5